Management of ST-Elevation Myocardial Infarction (STEMI)
Primary percutaneous coronary intervention (PCI) is the recommended first-line reperfusion strategy for STEMI patients when it can be performed within 90 minutes of first medical contact by experienced operators. 1
Initial Assessment and Immediate Management
- Immediate actions upon STEMI diagnosis:
- Administer 162-325 mg of non-enteric coated aspirin (chewed) immediately 1
- Add loading dose of P2Y12 inhibitor:
- Preferred: Ticagrelor 180 mg or Prasugrel 60 mg
- Alternative: Clopidogrel 600 mg 1
- Start anticoagulation immediately:
- Enoxaparin (preferred): 30 mg IV bolus followed by 1 mg/kg SC every 12 hours
- Unfractionated heparin: 60 U/kg IV bolus followed by 12 U/kg/hour infusion
- Bivalirudin: Alternative especially for patients with high bleeding risk 1
- Administer supplemental oxygen if arterial saturation <90% 1
- Consider morphine for pain and pulmonary congestion 1
Reperfusion Strategy Decision Algorithm
- Can primary PCI be performed within 120 minutes of first medical contact?
YES → Proceed with primary PCI
NO → Administer fibrinolytic therapy within 30 minutes of first medical contact
- Use fibrin-specific agent (tenecteplase, alteplase, or reteplase) 1
- Transfer patient immediately to PCI-capable center after fibrinolysis 1
- Perform angiography and PCI of infarct-related artery 2-24 hours after successful fibrinolysis 1
- Monitor for signs of failed fibrinolysis and be prepared for rescue PCI 1
Important Time Considerations
- Thrombolysis efficacy decreases significantly with time:
Contraindications to Thrombolysis
- Prior intracranial hemorrhage
- Known cerebrovascular lesion
- Recent major trauma or surgery
- Active bleeding or bleeding diathesis
- Suspected aortic dissection 1
Post-Reperfusion Medical Therapy
- Before discharge, initiate:
- Beta-blockers (start with low doses and titrate if heart failure present) 1
- ACE inhibitors with low initial dose unless systolic BP <100 mmHg 1
- Nitrates unless systolic BP <100 mmHg 1
- Consider aldosterone blockade for patients with LVEF ≤0.40 and either symptomatic heart failure or diabetes 1
- Consider diuretics if volume overload present 1
- Discontinue NSAIDs (except aspirin) due to increased risks 1
Secondary Prevention
- Continue dual antiplatelet therapy for at least 12 months after PCI 1
- Maintain statin therapy, beta-blockers, and ACE inhibitors (for indicated patients) 1
- Provide smoking cessation counseling, weight management, and physical activity recommendations 1
- Refer to cardiac rehabilitation 1
- Manage diabetes (goal HbA1c <7%) and blood pressure (goal <140/90 mmHg or <130/80 mmHg for CKD/diabetes) 1
Special Considerations
- For patients presenting 12-24 hours after symptom onset, PCI may still be beneficial if signs of ischemia/viability in the infarct-related area are present 2
- Patients with transient STEMI (resolution of symptoms and ECG changes before reperfusion) still benefit from early invasive approach with intense medical therapy 3
Pitfalls to Avoid
- Delaying reperfusion therapy - outcomes worsen significantly with time
- Failing to transfer patients to PCI-capable centers after fibrinolysis
- Overlooking dose adjustments for anticoagulants in patients with renal insufficiency 1
- Administering GP IIb/IIIa inhibitors "upstream" rather than selectively for high intracoronary thrombus burden 2